Cisatracurium besylate
CAS No. 96946-42-8
Cisatracurium besylate ( —— )
Catalog No. M16875 CAS No. 96946-42-8
Cisatracurium Besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
|
25MG | 58 | In Stock |
|
50MG | 102 | In Stock |
|
100MG | 170 | In Stock |
|
200MG | 250 | In Stock |
|
500MG | 428 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCisatracurium besylate
-
NoteResearch use only, not for human use.
-
Brief DescriptionCisatracurium Besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration.
-
DescriptionCisatracurium Besylate is a nondepolarizing skeletal muscle relaxant for intravenous administration. Cisatracurium Besylate acts on cholinergic receptors, blocking neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine. The neuromuscular block produced by cisatracurium besylate is readily antagonized by anticholinesterase agents once recovery has started. As with other nondepolarizing neuromuscular blocking agents, the more profound the neuromuscular block at the time of reversal, the longer the time required for recovery of neuromuscular function. Compared to other neuromuscular blocking agents, it is intermediate in its onset and duration of action.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorAChR; Adrenergic Receptor
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number96946-42-8
-
Formula Weight1243.48
-
Molecular FormulaC53H72N2O12·2C6H5O3S
-
Purity>98%(HPLC)
-
SolubilityEthanol: 249 mg/mL (200.24 mM); Water: 47 mg/mL (37.79 mM); DMSO: 249 mg/mL (200.24 mM)
-
SMILESC[N@@+]1(CCC2=CC(=C(C=C2[C@H]1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N@+]4(CCC5=CC(=C(C=C5[C@H]4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dieye E, et al. Ann Intensive Care. 2014 Feb 11;4(1):3.
molnova catalog
related products
-
GSK137647A
GSK137647A is a selective FFA4 agonist.
-
TA-03
TA-03 is a potent inhibitor of AChE in treatment of cognitive manifestation of AD.
-
NPS-1034
NPS-1034 is a dual Met/Axl inhibitor with IC50 of 48 nM and 10.3 nM, respectively.